结合MCL-1抑制和CD37导向的化学抗原受体T细胞作为向T细胞淋巴瘤的有效策略
Tayla B Heavican-Foral1,2,3, Felix Korell4, Irene Scarfò4,5
1Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Leukemia
|July 31, 2025
概括
化学抗原受体 (CAR) T细胞疗法通过向CD37.7对T细胞淋巴瘤 (TCL) 有希望. 在临床前模型中,将CAR-37 T细胞与BH3模仿细胞 (如AZD5991) 结合起来,可以增强抗TCL反应和生存.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞治疗是一种有前途的癌症治疗方法,但由于抗原识别困难,T细胞淋巴瘤 (TCL) 面临挑战.
- 在TCL患者的一个子集中,CD37已被确定在恶性T细胞上被选择性表达.
研究的目的:
- 开发和评估用于TCL治疗的向CD37的CAR T细胞.
- 研究CAR-37 T细胞与BH3模仿剂的组合,以提高治疗疗效并最大限度地降低毒性.
主要方法:
- 针对CD37阳性TCL的CAR-37T细胞的发展.
- 评估CAR-37T细胞活动,包括诱导细胞灭亡.
- 在TCL模型中识别可向的BH3依赖性.
- 使用CAR-37 T细胞和BH3模仿物 (例如,MCL-1的AZD5991) 的组合疗法研究.
- 对TCL细胞杀死,CAR-T细胞功能和异种移植小鼠体内疗效的组合治疗效果的评估.
主要成果:
- CAR-37 T细胞专门准CD37阳性TCL,并激活内在的亡途径.
- BH3模仿剂没有影响CD37结合或CAR-37T细胞功能.
- 在异种移植模型中,CAR-37 T 细胞与MCL-1 抑制剂 AZD5991 的结合显著增强了抗TCL反应,并延长了存活时间.
- TCL模型显示对特定的BH3蛋白质的依赖,表明个性化治疗策略.
结论:
- 对于CD37阳性TCL来说,CAR-37 T细胞治疗是一种可行的策略.
- 将CAR-37 T细胞与个性化的BH3模仿疗法结合起来,可以提高治疗指数和疗效.
- 这种组合方法有可能用于治疗TCL和潜在的其他血液性恶性瘤.
更多相关视频
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.5K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
800
相关概念视频
01:27Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K